Virbac has announced the launch of Canigen Lepto4 vaccine, which covers an additional two strains of Leptospirosis over its existing Canigen Lepto2 vaccine. 

The company says the new product is designed to give practices the flexibility to meet the needs of certain high-risk groups in the UK and in dogs which may be travelling abroad. 

Both vaccines are offered with technical training and support from Virbac. This includes a suite of educational and promotional resources to enable practices to engage with their clients and help to make informed decisions about Leptospirosis vaccination for their dog.

Sarah Walker MRCVS, Product Manager, said: "We are committed both to providing our practices with a full and flexible range of canine vaccines and to offering them all the support they need to advise their clients effectively on this important issue.  

"While Canigen Lepto2 is still perfectly suitable in many cases and provides a broad spectrum of protection, the launch of Canigen Lepto4 helps to offer a solution for those who may needed a broader degree of protection through being at a higher risk or those which travel abroad."

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.